INNOVATIVE APPROACHES IN CARDIOVASCULAR DISEASE

New Offer Price and approval of Supplemental Prospectus

OSLO, 24 May 2011

Serodus ASA has experienced broad interest from investors to participate in the initial public offering. However, based on feedback from investors, Serodus ASA has decided on 23 May 2011 to reduce its Offer Price from NOK 2 to NOK 1. The Subscription Price will be applicable for all subscriptions. Consequently the Offering will consist of an issue of 26 - 30 million New Shares giving total gross proceeds in the range of NOK 26 - 30 million.

A supplemental prospectus has on 23 May 2011 been 

approved by The Norwegian Supervisory Authority and 

can be obtained from www.serodus.com and 

www.terramarkets.no. For further information about the 

Offering please refer to the prospectus dated 23 May 

2011 which can be obtained from www.serodus.com and 

www.terramarkets.no 



Investors that have subscribed for Offer Shares in the 

Offering before the publishing of the Supplemental 

Prospectus have the right to withdraw their 

subscription within two days after the publishing of 

this Supplemental Prospectus, cf. the Norwegian 

Securities Trading Act section 7-21(2). The Manager 

will be in contact with those who have already 

subscribed.



The application period will end on 25 May 2011 at 

17:30 (CEST) and will not be subject to any 

extensions. 



The information in this announcement is subject to the 

disclosure requirements of the Norwegian Securities 

Trading Act section 5-12 and/or the Oslo Børs - 

Continuing Obligations.



For further information, please contact:

Håkon Sæterøy, Chariman, Serodus ASA

+47 926 95 175